Evidence of early ovarian aging in fragile X premutation carriers.
about
FMR1 genotype with autoimmunity-associated polycystic ovary-like phenotype and decreased pregnancy chanceUse of model systems to understand the etiology of fragile X-associated primary ovarian insufficiency (FXPOI)One world, one womanFragile X syndrome: the FMR1 CGG repeat distribution among world populationsContemporary genetic technologies and female reproductionClinical practice. Primary ovarian insufficiencyUnstable mutations in the FMR1 gene and the phenotypesRepeat-mediated genetic and epigenetic changes at the FMR1 locus in the Fragile X-related disordersThe FMR1 gene, infertility, and reproductive decision-making: a reviewStudy of the Genetic Etiology of Primary Ovarian Insufficiency: FMR1 GeneA clinical research integration special program (CRISP) for young women with primary ovarian insufficiencyBiomarkers in the Study of Families of Individuals with Developmental Disabilities.Fragile X-associated primary ovarian insufficiency: evidence for additional genetic contributions to severity.Approaches to identify genetic variants that influence the risk for onset of fragile X-associated primary ovarian insufficiency (FXPOI): a preliminary study.Genetic associations with diminished ovarian reserve: a systematic review of the literatureX-chromosome terminal deletion in a female with premature ovarian failure: Haploinsufficiency of X-linked genes as a possible explanationUnderstanding decreased fertility in women carriers of the FMR1 premutation: a possible mechanism for Fragile X-Associated Primary Ovarian Insufficiency (FXPOI).Elevated levels of FMR1 mRNA in granulosa cells are associated with low ovarian reserve in FMR1 premutation carriers.Ovarian aging and premature ovarian failure.The FMR1 gene and fragile X-associated tremor/ataxia syndrome.Altered hypothalamus-pituitary-adrenal gland axis regulation in the expanded CGG-repeat mouse model for fragile X-associated tremor/ataxia syndrome.Ovarian histopathological and ubiquitin-immunophenotypic features in fragile X-associated primary ovarian insufficiency: a study of five cases and selected controls.Ovarian abnormalities in a mouse model of fragile X primary ovarian insufficiency.One world, one woman: a kyosei approach to primary ovarian insufficiency.Improving Health Education for Women Who Carry an FMR1 Premutation.Granulosa cell and oocyte mitochondrial abnormalities in a mouse model of fragile X primary ovarian insufficiency.Primary ovarian insufficiency: a more accurate term for premature ovarian failure.Dizygotic twinning.The fragile X continuum: new advances and perspectives.Spontaneous premature ovarian failure: management challenges.FMR1: a gene with three faces.Top-down or bottom-up: Contrasting perspectives on psychiatric diagnosesEndocrine Dysfunction in Female FMR1 Premutation Carriers: Characteristics and Association with Ill Health.Abnormal uterine bleeding: a focus on polycystic ovary syndrome.A Theory for the Origin of Human Menopause.Reproductive tract function and dysfunction in women.Current understanding of ovarian aging.The ovarian response in fragile X patients and premutation carriers undergoing IVF-PGD: reappraisal.Genetics of primary ovarian insufficiency.Fragile X premutation in women: recognizing the health challenges beyond primary ovarian insufficiency.
P2860
Q21135603-4C2EF245-5C2E-4B1D-8436-84747628F0BEQ21198724-9D1362F0-7890-4648-9E23-9F5318B3A045Q24612879-88AD4BAD-CC2C-4D6E-8196-6DEB35B44759Q24629837-A6128101-72F0-4686-BA72-484FD66C9CCEQ24635098-FC167C0B-6ECD-42A6-A80E-7EAE49E6AA5DQ24653014-915CBEC1-22F5-4861-AAB1-D8633A2168ACQ26996649-167E4D93-FDCF-4A65-A8CA-14A5E9F9F038Q27011565-A6A9E36B-9428-4E3A-B62B-299A6672D2EEQ27026782-7597A8DB-B389-4669-906D-A7F40A835A14Q28077015-3C7E9477-02B6-4D4C-84F3-44E69B87376AQ28972322-BF4905B7-A686-48AB-9505-0DA06A9B0B71Q33795272-9E6B8132-7793-44F8-A8D8-6046CF4A0BF6Q33897004-5CA8BD88-67F9-49C9-A43D-6C03214FEF5EQ34013270-D6639BAE-2FFC-414B-94CA-8DC3AB6CBF71Q34037220-D0D407D1-B13A-42E1-900C-D3FE2F096B0FQ34043887-CF468504-65AB-4EA7-94CF-B8A21F795F23Q34077084-E73FBAEA-4C65-4E5D-BCC0-61D360ED8447Q34083509-BF583E53-4D7E-4D0E-A07D-2D1A6CF23D60Q34330442-12BD53E1-2F85-49DA-8C0B-1BA1A2B19D1CQ35061671-898E0397-3CFB-4A97-9C1C-3813E951DE15Q35533280-2931D1EC-ED46-4072-952A-1BAB9BE4CD56Q35563382-25A189D5-012C-4E7F-B14C-7A44C0B6F32EQ36085633-6B2001A3-D80E-49B6-91EE-F95CF6ED839CQ36761360-0F254695-8B95-4AA0-840E-1EBD981765A6Q36796993-743EBE31-2365-43A6-B8DE-29383E78139CQ36946491-B4E56B02-CA79-4BA0-859C-215C7431B409Q36985950-D7806DB4-FCF4-4B34-B0C7-691C845173ADQ37007519-06B64BB0-9844-4B04-91E1-9D324281C14CQ37150380-A7331D1B-D767-4473-BF5F-5DDF8BD8D5FDQ37196552-A94EC34A-8C42-4880-8BCA-B5CE2E3B76FDQ37216636-FFB946DB-01C5-4F09-9B48-F4D2D4BA9EA9Q37290726-28E9739A-23CF-4D15-9ED1-661727C7438CQ37449715-E33A3878-A24E-47F3-94C9-6CFAA4ADA9E0Q37458860-988B4551-DFB6-44A3-AFF0-A79F0E6BAAE8Q37562349-18D75D0B-5D9B-41BE-A593-A942593B3D53Q37879446-409BB93A-A664-4E76-80B0-5BAE64646DE2Q38038995-3F4B6DE8-D39B-431F-8A37-87E25A58B40BQ38804048-FB075AC4-450D-439F-B843-26A00CBD309BQ39012783-CA050E08-9BD4-45C9-A7A3-5C9EAF7D5E7BQ39044125-9A89689B-CABD-4FB2-8425-857483C79C9E
P2860
Evidence of early ovarian aging in fragile X premutation carriers.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Evidence of early ovarian aging in fragile X premutation carriers.
@en
Evidence of early ovarian aging in fragile X premutation carriers.
@nl
type
label
Evidence of early ovarian aging in fragile X premutation carriers.
@en
Evidence of early ovarian aging in fragile X premutation carriers.
@nl
prefLabel
Evidence of early ovarian aging in fragile X premutation carriers.
@en
Evidence of early ovarian aging in fragile X premutation carriers.
@nl
P356
P1476
Evidence of early ovarian aging in fragile X premutation carriers.
@en
P2093
P304
P356
10.1210/JC.2004-0347
P407
P577
2004-09-01T00:00:00Z